RIPE-KG · Version 1.1.0 · Resource
ripekg:work/10.1016%2Fj.chest.2020.09.281
https://w3id.org/ripe/ripe-kg/work/10.1016%2Fj.chest.2020.09.281
| Subject | Predicate | Object |
|---|---|---|
ripekg:work/10.1016%2Fj.chest.2020.09.281HAROSA I study group. Pitolisant for residual excessive daytime sleepiness in OSA patients adhering to CPAP: A randomized trial |
prism:doi |
10.1016/j.chest.2020.09.281 |
ripekg:work/10.1016%2Fj.chest.2020.09.281HAROSA I study group. Pitolisant for residual excessive daytime sleepiness in OSA patients adhering to CPAP: A randomized trial |
dcterms:title |
HAROSA I study group. Pitolisant for residual excessive daytime sleepiness in OSA patients adhering to CPAP: A randomized trial |
ripekg:work/10.1016%2Fj.chest.2020.09.281HAROSA I study group. Pitolisant for residual excessive daytime sleepiness in OSA patients adhering to CPAP: A randomized trial |
rdf:type |
node1 |
ripekg:work/10.1016%2Fj.chest.2020.09.281HAROSA I study group. Pitolisant for residual excessive daytime sleepiness in OSA patients adhering to CPAP: A randomized trial |
rdf:type |
http://purl.org/spar/fabio/Work |
ripekg:work/10.1016%2Fj.chest.2020.09.281HAROSA I study group. Pitolisant for residual excessive daytime sleepiness in OSA patients adhering to CPAP: A randomized trial |
rdf:type |
rdfs:Resource |
ripekg:work/10.1016%2Fj.chest.2020.09.281HAROSA I study group. Pitolisant for residual excessive daytime sleepiness in OSA patients adhering to CPAP: A randomized trial |
rdf:type |
owl:Thing |
ripekg:work/10.1016%2Fj.chest.2020.09.281HAROSA I study group. Pitolisant for residual excessive daytime sleepiness in OSA patients adhering to CPAP: A randomized trial |
rdf:type |
prov:Entity |
ripekg:work/10.1016%2Fj.chest.2020.09.281HAROSA I study group. Pitolisant for residual excessive daytime sleepiness in OSA patients adhering to CPAP: A randomized trial |
rdf:type |
ripe:WorkWork |
ripekg:work/10.1016%2Fj.chest.2020.09.281HAROSA I study group. Pitolisant for residual excessive daytime sleepiness in OSA patients adhering to CPAP: A randomized trial |
owl:sameAs |
https://semopenalex.org/work/W3119116175 |
ripekg:work/10.1111%2Fjsr.14373Pitolisant 40 mg for excessive daytime sleepiness in obstructive sleep apnea patients treated or not by <scp>CPAP</scp>: Randomised phase 3 study |
http://purl.org/spar/cito/cites |
ripekg:work/10.1016%2Fj.chest.2020.09.281HAROSA I study group. Pitolisant for residual excessive daytime sleepiness in OSA patients adhering to CPAP: A randomized trial |